Working Together for a Multi-Center Trial Effort to Stop ICI-Diabetes

Excited to work with our collaborators at UCSF, USC, U Colorado, and UNC Chapel Hill to move the field of cancer immune related adverse events and autoimmune diabetes closer to a cure at ENDO 2025 meeting in San Francisco.